November
AI with Purpose: Strategy-First Innovation Across Drug Discovery
Boston Chops DowntownOur Agenda
Solving AI-Driven Discovery at Scale – From Concept to Clinical Candidate
1Roundtable Tracks
3Designing FAIR-Centric Data Platforms for the Future of Multimodal R&D
4
Why you should attend
TOPICS INCLUDE:
• AI & ML implementation in drug discovery workflows
• Data interoperability across therapeutic areas and modalities
• FAIR data practices to enable reusability and collaboration
• Platform strategies that bridge chemistry and biology
Meet Our Facilitators
David Gosalvez, Ph.D
Chief Strategy Officer Revvity Signals
Dr. Anastasia Christianson
Life Science Senior Consultant and Strategic Adviser Former SVP and Head of AI, Data, and Analytics Pfizer
More about Revvity
Revvity Signals Software provides an extensive range of scientific solutions, empowering researchers and pharmaceutical pioneers worldwide. Our cutting-edge technology simplifies processes, speeds up experiments, and prioritizes promising compounds, redefining drug discovery. The Signals Research Suite, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. In addition, we have recently introduced Signals Synergy which is designed to substantially enhance collaboration, project management, and data exchange between sponsors and CROs.
Further Information
Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch
Here To Help
Need help registering your team? Just get in touch and a member of the team will be happy to help.
Payment Securely powered by stripe
